Covaxin
ICMR: Cocktail of Covaxin, Covishield is ‘safe, better’
The study was done by ICMR on 18 individuals who were inadvertently given a shot of Covaxin after their first dose of the Covishield in UP
Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India
The 5 vaccines granted EUA in India are SI's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson
After suspending EUA request, Brazil now shelves import authorisation of Covaxin
Bharat Biotech will continue to work diligently with Anvisa, to complete the regulatory approval process for Covaxin
Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact
Termination of the MoU came after the deal with the Brazilian Government for supply of 20 million doses of Covaxin landed in controversy
Second dose trial of Covaxin on 2-6 years to begin by next week
According to sources, children in the above-mentioned age group have already received the first dose of the vaccine
WHO assessing Covaxin data for EUL; Decision date 'to be confirmed'
Rolling data allows the WHO to start its review right away to accelerate the overall review process
Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates
The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech
The indigenous vaccine showed 63.6 per cent efficacy against the Delta variant of Covid-19
Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO
Swaminathan said WHO is reviewing Covaxin as its manufacturer Bharat Biotech is now uploading its entire data on the health body's portal
Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases